Literature DB >> 26094055

Optimization of radiation dosing schedules for proneural glioblastoma.

H Badri1, K Pitter2, E C Holland3, F Michor4,5, K Leder6.   

Abstract

Glioblastomas are the most aggressive primary brain tumor. Despite treatment with surgery, radiation and chemotherapy, these tumors remain uncurable and few significant increases in survival have been observed over the last half-century. We recently employed a combined theoretical and experimental approach to predict the effectiveness of radiation administration schedules, identifying two schedules that led to superior survival in a mouse model of the disease (Leder et al., Cell 156(3):603-616, 2014). Here we extended this approach to consider fractionated schedules to best minimize toxicity arising in early- and late-responding tissues. To this end, we decomposed the problem into two separate solvable optimization tasks: (i) optimization of the amount of radiation per dose, and (ii) optimization of the amount of time that passes between radiation doses. To ensure clinical applicability, we then considered the impact of clinical operating hours by incorporating time constraints consistent with operational schedules of the radiology clinic. We found that there was no significant loss incurred by restricting dosage to an 8:00 a.m. to 5:00 p.m. window. Our flexible approach is also applicable to other tumor types treated with radiotherapy.

Entities:  

Keywords:  Brain tumors; Linear-quadratic model; Nonlinear programming; Radiotherapy

Mesh:

Year:  2015        PMID: 26094055     DOI: 10.1007/s00285-015-0908-x

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  24 in total

1.  A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.

Authors:  G S Stamatakos; V P Antipas; N K Uzunoglu; R G Dale
Journal:  Br J Radiol       Date:  2006-05       Impact factor: 3.039

2.  A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model.

Authors:  Masahiro Mizuta; Seishin Takao; Hiroyuki Date; Naoki Kishimoto; Kenneth L Sutherland; Rikiya Onimaru; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

3.  Optimal solution for a cancer radiotherapy problem.

Authors:  A Bertuzzi; C Bruni; F Papa; C Sinisgalli
Journal:  J Math Biol       Date:  2013-01       Impact factor: 2.259

Review 4.  The linear-quadratic formula and progress in fractionated radiotherapy.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  1989-08       Impact factor: 3.039

Review 5.  Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.

Authors:  Frank Pajonk; Erina Vlashi; William H McBride
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

6.  A mathematical model for brain tumor response to radiation therapy.

Authors:  R Rockne; E C Alvord; J K Rockhill; K R Swanson
Journal:  J Math Biol       Date:  2008-09-25       Impact factor: 2.259

7.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

Authors:  Anne-Marie Bleau; Dolores Hambardzumyan; Tatsuya Ozawa; Elena I Fomchenko; Jason T Huse; Cameron W Brennan; Eric C Holland
Journal:  Cell Stem Cell       Date:  2009-03-06       Impact factor: 24.633

9.  Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Authors:  Cameron Brennan; Hiroyuki Momota; Dolores Hambardzumyan; Tatsuya Ozawa; Adesh Tandon; Alicia Pedraza; Eric Holland
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  10 in total

1.  Glioblastoma Recurrence and the Role of O6-Methylguanine-DNA Methyltransferase Promoter Methylation.

Authors:  Katie Storey; Kevin Leder; Andrea Hawkins-Daarud; Kristin Swanson; Atique U Ahmed; Russell C Rockne; Jasmine Foo
Journal:  JCO Clin Cancer Inform       Date:  2019-02

Review 2.  Mathematical models of tumor cell proliferation: A review of the literature.

Authors:  Angela M Jarrett; Ernesto A B F Lima; David A Hormuth; Matthew T McKenna; Xinzeng Feng; David A Ekrut; Anna Claudia M Resende; Amy Brock; Thomas E Yankeelov
Journal:  Expert Rev Anticancer Ther       Date:  2018-10-22       Impact factor: 4.512

3.  Tumor diversity and evolution revealed through RADseq.

Authors:  Elizabeth B Perry; Alvin Makohon-Moore; Caihong Zheng; Charles K Kaufman; Jun Cai; Christine A Iacobuzio-Donahue; Richard M White
Journal:  Oncotarget       Date:  2017-06-27

4.  A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer.

Authors:  Grant R Howard; Kaitlyn E Johnson; Areli Rodriguez Ayala; Thomas E Yankeelov; Amy Brock
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

5.  Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes.

Authors:  Yang Xiao; Dongjoo Kim; Burak Dura; Kerou Zhang; Runchen Yan; Huamin Li; Edward Han; Joshua Ip; Pan Zou; Jun Liu; Ann Tai Chen; Alexander O Vortmeyer; Jiangbing Zhou; Rong Fan
Journal:  Adv Sci (Weinh)       Date:  2019-02-10       Impact factor: 16.806

Review 6.  A Century of Fractionated Radiotherapy: How Mathematical Oncology Can Break the Rules.

Authors:  Nima Ghaderi; Joseph Jung; Sarah C Brüningk; Ajay Subramanian; Lauren Nassour; Jeffrey Peacock
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

7.  Integrating transcriptomics and bulk time course data into a mathematical framework to describe and predict therapeutic resistance in cancer.

Authors:  Kaitlyn E Johnson; Grant R Howard; Daylin Morgan; Eric A Brenner; Andrea L Gardner; Russell E Durrett; William Mo; Aziz Al'Khafaji; Eduardo D Sontag; Angela M Jarrett; Thomas E Yankeelov; Amy Brock
Journal:  Phys Biol       Date:  2020-11-20       Impact factor: 2.583

Review 8.  Optimal treatment and stochastic modeling of heterogeneous tumors.

Authors:  Hamidreza Badri; Kevin Leder
Journal:  Biol Direct       Date:  2016-08-23       Impact factor: 4.540

9.  Feasibility evaluation of micro-optical coherence tomography (μOCT) for rapid brain tumor type and grade discriminations: μOCT images versus pathology.

Authors:  Xiaojun Yu; Chi Hu; Wenfei Zhang; Jie Zhou; Qianshan Ding; M T Sadiq; Zeming Fan; Zhaohui Yuan; Linbo Liu
Journal:  BMC Med Imaging       Date:  2019-12-30       Impact factor: 1.930

10.  Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma.

Authors:  Jes Alexander; Quincey C LaPlant; Siobhan S Pattwell; Frank Szulzewsky; Patrick J Cimino; Francesca P Caruso; Pietro Pugliese; Zhihong Chen; Florence Chardon; Andrew J Hill; Cailyn Spurrell; Dakota Ahrendsen; Alexander Pietras; Lea M Starita; Dolores Hambardzumyan; Antonio Iavarone; Jay Shendure; Eric C Holland
Journal:  Glia       Date:  2020-07-04       Impact factor: 7.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.